Product Description: GPR183-IN-1 (compound 15) is a potent and orally activity GPR183 inhibitor. GPR183-IN-1 inhibits Ca2+ mobilization with an IC50 value of 39.97 nM. GPR183-IN-1 has the potential for the research of cancer, autoimmune diseases, pain, and osteoporosis[1].
Formula: C16H19BrN2O2
References: [1]JianFei Xi, et al. Compounds and their use as GPR183 inhibitors. CN118201911A.
CAS Number: 2924063-70-5
Molecular Weight: 351.24
Research Area: Cancer; Inflammation/Immunology; Neurological Disease
Target: EBI2/GPR183